Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus

NCT04665284 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

244

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: Empagliflozin
DRUG: Usual care group

Sponsor

Getz Pharma